You are viewing Sub-Saharan Africa

Choose Your Location:
  • United States
  • Canada
  • Latin America
  • EMENA
  • Sub-Saharan Africa
  • Russia
  • South Asia
  • Asia Pacific
  • China
  • Global

Choose Your Location:

usa-noactive usa-active
United States
canada-noactive canada-active
Canada
latin-america-noactive latin-america-active
Latin America
north-america-noactive emena-active
EMENA
Africa Africa
Sub-Saharan Africa
Russia Russia
Russia
South Asia South Asia
South Asia
Asia Asia
Asia Pacific
China China
China
global-site-noactive global-site-active
Global

Assessing the Efficacy of MEFLUVAC™ H9N2 inactivated vaccine strain (A/Chicken/Egypt/ME/543V/2016) in association with a bivalent live IB-ND vaccine

Technical Literature

Discover the efficacy of MEFLUVAC™ H9N2 inactivated vaccine strain (A/Chicken/Egypt/ME/543V/2016) in association with a bivalent live IB-ND vaccine.

Download our technical literature to learn how this study assesses the effectiveness of the LPAI H9 vaccine in the presence of a bivalent live attenuated IB-ND vaccine known as MEVAC™ ELI-VAR 2 (Vaccine 2), which contains Infectious Bronchitis virus (GI-23 lineage VAR 2 strain) and Newcastle Disease virus (GII VG/GA strain).

Mockup-Technical-Literature-7-TCP

Fill out the form below to download the trial data